Oral cancer screening: what have we learnt and what is there still to achieve?
- PMID: 20146588
- DOI: 10.2217/fon.09.163
Oral cancer screening: what have we learnt and what is there still to achieve?
Abstract
Oral cancer is an important global healthcare problem. In the UK, the incidence is increasing and late-stage presentation is common. Determining the feasibility of a national screening program for oral cancer is therefore an important step in the prevention of the disease. Evidence exists to suggest that an oral examination of high-risk individuals may be a cost-effective screening strategy. However, questions remain over which primary care environment would be the most suitable and the criteria for a positive screen and referral. Further research is needed in the form of clinical trials or demonstration studies in primary care. The impact on secondary care, the role of auxiliaries and training needs also need to be determined. In addition, the assessment of adjunctive aids and evaluation of potential biomarkers are considered important.
Similar articles
-
Prevention of oral carcinoma.Dent Update. 1990 Mar;17(2):58-61. Dent Update. 1990. PMID: 2376274
-
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas.Tex Dent J. 2012 May;129(5):491-507. Tex Dent J. 2012. PMID: 22779205
-
Preventive health care, 1999 update: prevention of oral cancer mortality. The Canadian Task Force on Preventive Health Care.J Can Dent Assoc. 1999 Dec;65(11):617. J Can Dent Assoc. 1999. PMID: 10859725
-
Oral cancer: Premalignant conditions and screening--an update.J Cancer Res Ther. 2012 Jan;8 Suppl 1:S57-66. doi: 10.4103/0973-1482.92217. J Cancer Res Ther. 2012. PMID: 22322734 Review.
-
The dental hygienist's role in screening for oral cancer.Probe. 1995 Mar-Apr;29(2):53-6, 58-9. Probe. 1995. PMID: 9518776 Review. English, French. No abstract available.
Cited by
-
MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy.Cancers (Basel). 2022 Sep 23;14(19):4625. doi: 10.3390/cancers14194625. Cancers (Basel). 2022. PMID: 36230547 Free PMC article. Review.
-
Clinical Significance of the Decreased Expression of hsa_circ_001242 in Oral Squamous Cell Carcinoma.Dis Markers. 2018 Jul 4;2018:6514795. doi: 10.1155/2018/6514795. eCollection 2018. Dis Markers. 2018. PMID: 30069275 Free PMC article.
-
Circ_0000140 restrains the proliferation, metastasis and glycolysis metabolism of oral squamous cell carcinoma through upregulating CDC73 via sponging miR-182-5p.Cancer Cell Int. 2020 Aug 26;20:407. doi: 10.1186/s12935-020-01501-7. eCollection 2020. Cancer Cell Int. 2020. PMID: 32863766 Free PMC article.
-
LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.Cancer Med. 2017 Dec;6(12):2897-2908. doi: 10.1002/cam4.1253. Epub 2017 Nov 10. Cancer Med. 2017. PMID: 29125238 Free PMC article.
-
Naa10p Enhances Chemosensitivity to Cisplatin in Oral Squamous Cell Carcinoma Cells.Cancer Manag Res. 2021 Feb 22;13:1843-1851. doi: 10.2147/CMAR.S296783. eCollection 2021. Cancer Manag Res. 2021. PMID: 33658848 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical